Serum Procalcitonin Is a Candidate Biomarker to Differentiate Bacteremia from Disease Flares in Patients with Inflammatory Bowel Dis

참고문헌 (9)

1. Schuetz P, "Procalcitonin for diagnosis of infection and guide to antibiotic decisions: past, present and future", BMC Med, 9, pp.107~ (2011)
2. Schuetz P, "Serum procalcitonin for discrimination of blood contamination from bloodstream infection due to coagulase-negative staphylococci", Infection, 35, pp.352~355 (2007)
3. 양동훈, "Usefulness of C-Reactive Protein as a Disease Activity Marker in Crohn’s Disease according to the Location of Disease", Gut and Liver, 9(1), pp.80~86 (2015), 거트앤리버 발행위원회
4. van Nieuwkoop C, "Procalcitonin reflects bacteremia and bacterial load in urosepsis syndrome: a prospective observational study", Crit Care, 14, pp.R206~ (2010)
5. Delèvaux I, "Can procalcitonin measurement help in differentiating between bacterial infection and other kinds of inflammatory processes?", Ann Rheum Dis, 62, pp.337~340 (2003)
6. 주고운, "Serum Procalcitonin for Differentiating Bacterial Infection from Disease Flares in Patients with Autoimmune Diseases", Journal of Korean Medical Science, 26(9), pp.1147~1151 (2011), 대한의학회
7. Gogos CA, "Pro- versus antiinflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options", J Infect Dis, 181, pp.176~180 (2000)
8. de Kruif MD, "The influence of corticosteroids on the release of novel biomarkers in human endotoxemia", Intensive Care Med, 34, pp.518~522 (2008)
9. Sook Hee Chung, "Usefulness of Measuring Serum Procalcitonin Levels in Patients with Inflammatory Bowel Disease", Gut and Liver, 10(4), pp.574~580 (2016), 거트앤리버 발행위원회

관련 논문AI추천